← FDA Drug Approvals (Drugs@FDA)
TEMBEXA
NDA · New Drug Application · Sponsor: EMERGENT BIODEFENSE · Approved 2021-06-04
Drug application
- FDA Application #
NDA214461- Application type
- New Drug Application
- Brand name
- TEMBEXA
- Generic name
- BRINCIDOFOVIR
- Active ingredients
- BRINCIDOFOVIR
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- EMERGENT BIODEFENSE
- Manufacturer
- Emergent BioDefense Operations Lansing LLC
- First approval
- 2021-06-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown